Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
EKSO BIONICS (EKSO)
NASDAQ:EKSO
EKSO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.47 - $2.16
Previous CloseN/A
Volume1.71M
Average Volume (3M)528.87K
Market Cap
$12.33M
Enterprise Value$21.61M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Feb 27, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.65
Shares Outstanding21,998,370
10 Day Avg. Volume233,354
30 Day Avg. Volume528,867
Standard Deviation0.27
R-Squared0.08
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)-1.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.75
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.38
Enterprise Value/Ebitda-2.41
Forecast
1Y Price Target
$5.50Price Target Upside900.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Bulls Say, Bears Say
Bulls Say
Market DemandManagement noted increased demand in Europe, where it expects strong sales.
Revenue GrowthQuarterly revenue growth promising.
Bears Say
Cash FlowThe company’s present forecasts suggest less than 12 months of cash runway, indicating a likely need to tap the equity markets.
---
Ownership Overview
6.31% Insiders
3.37% Mutual Funds
12.55% Other Institutional Investors
75.13% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
EKSO FAQ
What was EKSO BIONICS’s price range in the past 12 months?
EKSO BIONICS lowest stock price was $0.47 and its highest was $2.16 in the past 12 months.
What is EKSO BIONICS’s market cap?
EKSO BIONICS’s market cap is $12.33M.
When is EKSO BIONICS’s upcoming earnings report date?
EKSO BIONICS’s upcoming earnings report date is Feb 27, 2025 which is in 4 days.
How were EKSO BIONICS’s earnings last quarter?
EKSO BIONICS released its earnings results on Oct 28, 2024. The company reported -$0.1 earnings per share for the quarter, beating the consensus estimate of -$0.105 by $0.005.
Is EKSO BIONICS overvalued?
According to Wall Street analysts EKSO BIONICS’s price is currently Undervalued.
Does EKSO BIONICS pay dividends?
EKSO BIONICS does not currently pay dividends.
What is EKSO BIONICS’s EPS estimate?
EKSO BIONICS’s EPS estimate is -0.08.
How many shares outstanding does EKSO BIONICS have?
EKSO BIONICS has 21,998,370 shares outstanding.
What happened to EKSO BIONICS’s price movement after its last earnings report?
EKSO BIONICS reported an EPS of -$0.1 in its last earnings report, beating expectations of -$0.105. Following the earnings report the stock price went down -15.044%.
Which hedge fund is a major shareholder of EKSO BIONICS?
Currently, no hedge funds are holding shares in EKSO
---
Company Description
EKSO BIONICS
Ekso Bionics Holdings, Inc. engages in the design, development, and sale of exoskeleton technology that currently has applications in healthcare and industrial markets. It operates through the following business segments: EksoHealth, EksoWorks, and Other. The EksoHealth segment consists of the engineering, manufacture, and sale of exoskeletons for applications in the medical markets. The EksoWorks segment offers exoskeleton devices to allow able-bodied users to perform heavy duty work for extended periods. The company was founded on January 30, 2012 and is headquartered in Richmond, CA.
---
EKSO Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in CMS claim approval and international sales growth, with improved gross margins and reduced operating expenses, leading to a reduced net loss. However, revenue declined year-over-year with challenges in U.S. sales and the industrial segment.Read More>---
EKSO Stock 12 Month Forecast
Average Price Target
$5.50
▲(900.00% Upside)
Technical Analysis
Best Analysts Covering EKSO
1 Year
1 Year Success Rate
1/10 ratings generated profit
1 Year Average Return
-35.66%
reiterated a buy rating last month
Copying Swayampakula Ramakanth's trades and holding each position for 1 Year would result in 10.00% of your transactions generating a profit, with an average return of -35.66% per trade.
---